Has Staci Graf, MD received payments from drug or device companies?

Yes. Drug and device makers reported $482 in general payments to Staci Graf, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Staci Graf, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Staci Graf, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Staci Graf, MD

Neurology · Hinsdale, ILNPI 1548585128

Payments from drug & device makers

$482in general payments, 2019–2025

Across 20 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$257
EMD Serono, Inc.$128
Lilly USA, LLC$35
Teva Pharmaceuticals USA, Inc.$30
Novartis$18
Amneal Pharmaceuticals LLC$13

What the payments were for

Food & beverage$482100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	13	$257
EMD Serono, Inc.	2	$128
Lilly USA, LLC	2	$35
Teva Pharmaceuticals USA, Inc.	1	$30
Novartis	1	$18
Amneal Pharmaceuticals LLC	1	$13

How this compares

$482 in reported general payments places this provider in the 45th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois →

Medicare billing

Part B allowed, 2024

$104,450

Medicare patients

490

Services billed

726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Emgality PenGalcanezumab-Gnlm	27	$24,091
Aimovig AutoinjectorErenumab-Aooe	13	$15,458
Memantine Hcl	204	$4,992
Lacosamide	42	$4,156
Gabapentin	140	$3,534
Levetiracetam	130	$3,414
Carbidopa-LevodopaCarbidopa/Levodopa	126	$3,086
Pregabalin	114	$2,575
Propranolol Hcl ErPropranolol Hcl	41	$1,483
Donepezil Hcl	169	$1,475
Duloxetine Hcl	51	$1,434
Primidone	22	$1,425
Carbamazepine ErCarbamazepine	13	$992
Phenytoin Sodium Extended	23	$614
Amitriptyline Hcl	38	$589

Paid to pharmacies, not to this prescriber.

Other neurology in Hinsdale

Rizwan BajwaHinsdale$288K
Daniel WynnNorthbrook$13.9M
Concetta ForchettiElk Grove Village$8.5M
Tatyana SimuniChicago$3.5M
Danny BegaChicago$2.8M
Thomas AlaSpringfield$2.4M
Augusto MiravalleChicago$2.1M
Leonard Verhagen MetmanChicago$1.8M
Anthony RederBurr Ridge$1.6M
Dusan StefoskiChicago$1.5M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →